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mammographyAbstract Objective: To assess the impact of digital breast tomosynthesis (DBT) and magnetic
resonance mammography (MRM) in enhancing the performance of digital mammography (DM)
in the detection and evaluation of different breast lesions.
Patients and methods: In this retrospective study, 98 patients with 103 breast lesions were assessed by
DM,DBTandMRM.Mammography imageswere acquired using the ‘‘combomode",where bothDM
and DBT scanned in the same compression.MRMwas performed by 1T open system. Each lesion was
assigned a blinded category in an individual performance for each modality. The resultant BI-RADS
categories were correlated with reports of the pathology specimens or outcome of 18-month follow-up.
Results: Both DBT and MRM showed equivalent sensitivity of 92%. The specificity for DBT and
MRM was 80.7% and 89.7% respectively. The efficacy of DM was raised from 61% to 83.5% with
DBT and 90.2% with MRM. The results of the three modalities and the final diagnosis revealed a sig-
nificant correlation (p= 0.035).The association between the results ofDBTand those ofMRMshowed
statistically significant difference between DBT and MRM for diagnosing breast lesions (p= 0.001).
Conclusion: BothMRMandDBTprovide better performance than classicDM.Adding either of these
modalities to the classic examination enhances diagnosis and precise disease distribution.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).ElAiny
1160 R. Kamal et al.1. Introduction
Optimal treatment and prognosis assessment require accurate
diagnosis. Mammography still has its special place in breast
imaging of symptomatic women, yet its low sensitivity due to
the misinterpretation of architectural distortion, asymmetrical
density, and overlapping glandular tissue obscuring cancer
limited its sole application (1).
Breast tomosynthesis is a new technology of digital mam-
mography that enables the acquisition of a three-dimensional
volume of thin section data, and thus reduces or eliminates
tissue overlap (2). Such ability allows visualization of cancers
not apparent by conventional mammography (3) and differen-
tiation between benign and malignant lesions (2).
Breast MR imaging has also become an important and
powerful tool in breast imaging (4).
MRI is not influenced by breast density. Therefore, it may
help to characterize the lesion (5), and provide valuable
information about breast cancer (4).
After a very promising start of MR of the breast in the
clinical practice, a variety of difficulties and obstacles were
identified, for example: the lack of standardization of image
acquisition, paucity of MR-compatible interventional devices,
and the debate about its specificity and positive predictive
value, and also its sensitivity for ductal carcinoma in situ (6).
The purpose of this study was to assess the role of 3-D
breast tomosynthesis in the confirmation/exclusion of breast
lesions detected on inconclusive digital mammogram and since
tomosynthesis is a multislice modality, we evaluated its impact
on characterization and consequently diagnosis whether
benign or malignant in comparison with MR mammography.2. Patients and methods
This study is a retrospective analysis approved by the Ethics
Committee in Wadi El-Neel Hospital and waiver of informed
consent was applied for the used data of the included cases.
The study started at January 2013 till June 2014 included 98
patients with 103 breast lesions. Patients’ age ranged from 25
to 81 years with a mean of 48.6.
2.1. Patients
Ninety-eight patients were referred from the outpatient clinics
of both General Surgery and Oncology (after having clinical
breast examination) to the Radiology Department of our
institution.
Our inclusion criteria were as follows:
 The presence of palpable lump detected by clinical breast
examination in mammograms of heterogeneously and
extremely dense breasts (ACR ‘‘c” and ‘‘d”).
 Mammograms of inconclusive pathology discrimination
(i.e. BI-RADS 3 and 4 category).
Exclusion criteria were as follows:
 Diagnostic mammograms with distinct BI-RADS category
whether benign or malignant: (i) BI-RADS 2 that showed
rounded masses with macrocalcifications; scatteredmacro- or microcalcifications and masses or densities with
fat radio-lucency within. (ii) BI-RADS 5 that showed
spiculated masses with or without microcalcifications.
 Contraindication of MR examination: pacemaker,
aneurysm clip, or the presence of metallic foreign body in
or near the eye, ear or teeth.
 Patients with renal impairment (eGFR> 30 ml
/min/1.73 m2), being contraindicated to contrast injection.
2.2. Methods
Cases were assessed by bilateral DM, DBT and MRM.
A complementary ultrasound examination performed for
all cases using both B-mode and elastography ultrasound on
Aplio XG device (Toshiba, Japan) to confirm or exclude
mammography identified abnormalities. Examination was
done by 6–9 MHz high frequency probe.
2.2.1. Mammography examination
A combined full field DM and 3D tomosynthesis examinations
were done using Hologic Selenia Dimensions Digital
Tomosynthesis System using the following steps:
 Position views: Images of both breasts are taken in the
cranio-caudal and mediolateral oblique views.
 Acquisition: The system attains a ‘‘Combo-mode” imaging
technique (2D + 3D imaging) that acquires a traditional
digital mammogram and a tomosynthesis scan in the same
compression. During a tomosynthesis scan, multiple (7–11),
low-dose images of the breast are acquired at different
angles while the X-ray tube moves in an arc across the
breast. These images are then used to produce a series of
one-millimeter thick images (from 60 to 90 slices, according
to the breast size) that can be reconstructed to a three
dimensional image of the breast.
 Display methodology: Images are displayed on dedicated
high resolution workstations with special capabilities that
are tailored for breast imaging. The re-constructed
tomosynthesis images can be viewed as one slice at a time
or in a cine loop.
2.2.2. Magnetic resonance imaging
Examinations were performed on ‘‘Panorama” 1.0T open MR
system, with an image quality equivalent to that of a 1.5 T
cylindrical system (Philips Medical Systems, Netherlands.).
We used bilateral breast surface coil and the patient was in
the prone position.
Total study time ranged from 30 to 45 min.
The routine MR imaging examination included the
following:
A-Localizer scout views in the sagittal orientations.
B-Pre-contrast series: axial T1-weighted turbo spin echo
(TR/TE = 418/10 ms), axial T2-weighted turbo spin echo
(TR/TE = 4.8 s /120 ms) and axial short tau inversion recovery
(STIR) (TR/TE = 6.5 s /80 ms; inversion time = 150 ms) as
well as sagittal T2 turbo spin echo weighted sequences. Slice
thickness = 4 mm, matrix = 512  192, FOV= 340–370 mm.
C-Post-contrast series: Seven dynamic acquisitions, one
before and six after intravenous injection 0.1 mmol/kg body
Table 1 The final outcome for the studied population.
Outcome = 98 lesions No. (%)
Benign 78 (75.7)
Fibroadenoma 17 (17.3)
Fibrocystic changes 13 (13.3)
Postoperative sequelae 11 (11.2)
Apparent focal fibroglandular tissue 8 (8.1)
Hamartoma 5 (5.1)
Lymph node 5 (5.1)
Simple cyst 4 (4)
Fat necrosis 4 (4)
Granulomatous mastitis 3 (3)
Tuberculous abscess 1 (1)
Benign ductal epithelial proliferation 2 (2)
Sclerosing adenosis 2 (2)
Fibroadenosis 2 (2)
Intracystic papilloma 1 (1)
Malignant 25 (24.3%)
Invasive ductal carcinoma 18 (18.3)
Ductal carcinoma in situ 7 (7.1)
Table 2 The distribution of the BIRADS scores for DM,
DBT and MRM within the studied population.
BI-RADS category DM DBT MRM
BI-RADS 1 3 (2.9) 7 (6.8) 7 (6.8)
BI-RADS 2 18 (17.5) 42 (40.8) 49 (47.6)
BI-RADS 3 23 (22.3) 16 (15.5) 17 (16.5)
BI-RADS 4 59 (57.3) 22 (21.4) 16 (15.5)
BI-RADS 5 16 (15.5) 14 (13.6)
Note: Data are reported as number (percent).
Table 3 The diagnostic outcome for DM, DBT and MRM
BIRADS scores.
Diagnostic outcome DM DBT MRM
False negative 3 (2.9) 2 (1.9) 2 (1.9)
False positive 37 (35.9) 15 (14.6) 8 (7.8)
True negative 41 (39.8) 63 (61.2) 70 (68)
True positive 22 (21.4) 23 (22.3) 23 (22.3)
Note: Data are reported as number (percent).
Fig. 1 Represents the diagnostic indices of the various imaging
modalities included in the current study.
Table 4 Mammography versus tomosynthesis BIRADS
scores.
Mammography BIRADS count Tomosynthesis
BIRADS
Total
1 2 3 4 5
1 2 1 0 0 0 3
2 0 17 0 1 0 18
3 1 11 11 0 0 23
4 4 13 5 21 16 59
Total 7 42 16 22 16 103
P value: 0.00.
Breast tomosynthesis and MR mammography in evaluation of breast lesions 1161weight of contrast material (gadolinium-diethylene tri amino
penta acetic acid; Gd-DTPA), using the dynamic THRIVE
sequence (T1 High Resolution Isotropic Volumetric
Examination) (TR/TE = 7/3 ms) of slice thickness = 1.5 mm.
Kinetics of the lesions was assessed and signal intensity-
time curves were obtained.
2.3. Image analysis
Standard DMs were first interpreted (by K.R. of 27 years
experience) and then DBT images were first interpreted by
another independent reader (M.D. of 12 years experience).
According to the ‘‘Breast Imaging Data and Reporting
System” (12), mammograms of all patients were assigned an
initial BIRADS category in view of their DM and DBT
findings.
The images were assessed for the presence of the following:
(i) masses described in terms of shape and margins; (ii) asym-
metry whether focal or global, (iii) area of architectural
distortion, (iv) microcalcifications regarding shape and
distribution and (v) other findings as nipple retraction, skin
thickening, skin dimpling, enlarged axillary nodes and anterior
chest wall extension.
MR images of the included cases were evaluated by two
individual radiologists as well (M.S. and M.K. of 17 and
10 years experience).
Abnormalities looked for were as follows: (i) masses
described by shape, border and internal signal intensity (SI)
and enhancement pattern, (ii) non-mass area of abnormal SI
or differential enhancement, (iii) suspicious focus or foci, (iv)
other findings such as edema, nipple retraction, lymphadenopa-
thy, nipple invasion, pectoralis muscle invasion, chest wall
invasion, skin thickening (focal/diffuse), hematoma/blood
and skin invasion and (v) kinetic curve assessment into initial
rise: slow, medium, rapid and delayed phase: persistent,
plateau, washout.
Another BIRADS category was assigned for the MR
mammography.
Fig. 2 Forty-three year old lady with right breast non-specific granulomatous mastitis, multifocal suppuration and chronic abscess
formations. (a) Digital mammography CC view of the right breast: edema pattern, evident by overall increased breast density, thickened
interstitium and circumferential skin thickening; BI-RADS 4. (b) Three-dimensional tomosynthesis multiple slices in the same projection
showed confirmation of the breast edematous changes, and there are multiple lucent areas seen related (i.e. cavitory lesions) (white
arrows); BIRADS 3. (c) Axial T2WI FSE (right image) and T2 STIR WI (left image). There is a diffuse breast involvement by an ill-
defined complex process of high signal intensity and related multiple foci of tissue liquefaction. (d) Axial post contrast images showed
early intense heterogonous enhancement with marginal enhancement of the cavitory lesions and kinetics showed early peak of contrast
uptake at 2–3 min with corresponding signal intensity percentage of 70–80%, followed by plateau curve pattern (represents suspicious
curve); BI-RADS 4. Both DBT and the morphological assessment of MRM suggested inflammatory process yet the MR post contrast
kinetics raises the suspicion of malignancy and suggested biopsy.
1162 R. Kamal et al.
Fig. 2 (continued)
Table 5 Mammography versus MR mammography BIRADS
scores.
Mammography BIRADS MRI BIRADS Total
1 2 3 4 5
1 2 1 0 0 0 3
2 0 14 2 0 2 18
3 1 12 6 4 0 23
4 4 22 9 12 12 59
Total 7 49 17 16 14 103
P value: 0.00.
Breast tomosynthesis and MR mammography in evaluation of breast lesions 1163Negative studies whether mammogram or MR
mammography were assigned BI-RADS 1.
Examinations with BIRADS scores of 1–3 in our analysis
were considered benign and scores of 4 and 5 were considered
malignant.
According to the ACR guidelines, for lesions assigned
BIRADS scores of 4 or 5, tissue analysis was obtained.The resultant BIRADS scores for each modality were
correlated with the final diagnosis based on the data supplied
by tissue biopsy/pathological specimen of the selected
abnormality.
On the other hand, those assigned BIRADS scores of 2
and 3 were followed up (annual follow-up for BIRADS 2
lesions and follow-up at 6 months interval for BIRADS 3
lesions).
Twenty-three lesions presented benign criteria (four simple
cysts, two fibroadenosis, five lymph nodes, six postoperative
sequelae, two hamartomas and four asymmetrical
fibroglandular tissues) and consequently their final diagnosis
was confirmed by stationary or regressive disease course.
The authors were blinded regarding the image analysis
performed by each of them and both the initial DBT and
re-evaluation by MR mammography performed without
knowledge of the pathology results. At the stage of final
evaluation, there was multidisciplinary discussion of
findings with the radiologists and the breast surgery consultant
(H. A.).
Fig. 3 Female patient 37-year-old presented with right breast tenderness and induration. (a) Digital mammogramMLO view of the right
breast of dense parenchyma (ACR ‘‘d”) that showed partly scalloped and partly ill-defined densities (straight arrows), cluster of
microcalcific foci (encircled), enlarged suspicious axillary lymphadenopathy (bracket), focal areolar dermal thickening and nipple traction;
BIRADS 4C. (b) Right DBT MLO view showed more distinct outlines of the right breast abnormality seen eliciting lobulated defined
outline (arrows) with numerous lucent areas therein. The microcalcific cluster detected (circle) as well as the enlarged axillary nodes was
the main feature that supported BI-RADS 4. (c) Axial T2 FSE WI (right image) and T2 STIR WI (left image) displayed right breast large
cystic mass with turbid fluid (intermediate T2 signal) content and thickened walls. There is enlarged ipsilateral axillary node with
asymmetrical cortical thickening and minimal pre-pectoral edema. (d) Axial subtraction post contrast image and (e) Time/signal intensity
curves for the areas of contrast uptake showed Ring (mural) enhancement of the right breast mass (arrows) that elicited progressively
rising pattern (benign behavior) curves; features that suggested complicated infected cavitory mass and BI-RADS 3 category. Pathology
revealed tuberculous abscess and MRM presented the most comparable BI-RADS score to the final outcome.
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Fig. 3 (continued)
Table 6 Tomosynthesis versus MRI BIRADS scores.
Tomosynthesis BIRADS MRI BIRADS Total
1 2 3 4 5
1 6 0 0 1 0 7
2 1 36 3 1 1 42
3 0 4 9 3 0 16
4 0 7 4 9 2 22
5 0 2 1 2 11 16
Total 7 49 17 16 14 103
P value: 0.00.
Breast tomosynthesis and MR mammography in evaluation of breast lesions 11652.4. Statistical analysis
Results are expressed as mean ± standard deviation or num-
ber (%). Comparison between categorical data was performed
using Chi square test. Standard diagnostic indices including
sensitivity, specificity, positive predictive value (PPV), negative
predictive value (NPV) and diagnostic efficacy were calculated.
SPSS computer program (version 12 windows) was used for
data analysis. P value less or equal to 0.05 was considered
significant and less than 0.01 was considered highly significant.
3. Results
According to the pathological final diagnosis, 78 masses
(75.7%) were considered benign and the remaining 25
(24.3%) were considered malignant.
Table 1 lists the distribution of benign and malignant
diagnosis in the current work.
3.1. Mammography
Three mammograms were assigned a BIRADS score of 1
(2.9%), 18 lesions were assigned score 2 (17.5%), 23 lesions
were assigned score 3 (22.3%) and the remaining 59 lesions
were assigned score 4 (57.3%).
Concerning standard digital mammography, false negative
was three in number (2.9%), 37 lesions were false positive(35.9%), 41 lesions were true negative (39.8%) and 22 lesions
were true positive (22%).
So, mammography had a sensitivity of 88%, a specificity of
52.56%, a positive predictive value of 37.29%, a negative
predictive value of 93.18% and accuracy of 61.17%.
3.2. Tomosynthesis
BIRADS score of 1 was given to seven mammograms (6.8%),
score 2–42 lesions (40.8%), score 3–16 lesions (15.5%), and
score 4–22 lesions (21.4%) and 16 lesions were assigned a
BIRADS score of 5 (15.5%).
The diagnostic outcome in two cases was false negative
(1.9%), 15 cases was false positive (14.6%), 63 cases was true
negative (61.2%) and 23 was true positive (22.3%).
The sensitivity of 3 D tomosynthesis in evaluating breast
lesions was 92%, the specificity was 80.77%, the positive
predictive value was 60.53%, and the negative predictive value
was 96.92%, while the efficacy was 83.5%.
3.3. MRM
Comparable to DBT, according to the MRM findings seven
lesions were assigned a BIRADS score of 1 (6.8%).
The BI-RADS category of the remaining 96 lesions was as
follows: score 2 for 49 lesions (47.6%), score 3 for 17 lesions
(16.5%), score 4 for 16 lesions (15.5%) and finally score 5
for 14 lesions (13.6%).
MRM diagnosis was false negative in two cases (1.9%),
false positive in 8 lesions (7.8%), true negative in 70 lesions
(68%) and true positive in 23 lesions (22.3%).
Therefore, the sensitivity of MRM was 92%, the specificity
was 89.74%, the positive predictive value was 74.19%, the
negative predictive value was 97.22% and efficacy was 90.29%.
The distribution of the BIRADS scores and the diagnostic
outcome for assigned BI-RADS category for DM, DBT and
MRM are presented in Tables 2 and 3 respectively.
Fig. 1 represents the diagnostic indices of the various
imaging modalities included in our study.
The relation between mammography BIRADS scores and
those of tomosynthesis revealed a highly significant correla-
tion, having a p-value of 0.001 (p-values < 0.01 are considered
highly significant). This is represented in Table 4.
Fig. 4 Forty-one year old lady with a palpable right breast mass pathology revealed multicentric invasive ductal carcinoma. (a) Digital
mammography CC (right image) and MLO (left image) views of the right breast: upper outer multiple masses (white arrows) of partly ill-
defined and partly obscured borders; BI-RADS 5. (b) Multiple slices DBT CC view showed more masses of multicentric (white arrows)
rather than multifocal distribution. Axial (c) T2 STIR and (d) subtraction early post contrast: right breast upper outer and central multiple
ill-defined masses (i.e. multicentric) (white arrows); BI-RADS 5 that showed plateau pattern of time/signal intensity curves seen at (e).
MRM and DBT confirmed the final outcome and showed more accurate disease distribution than DM required for precise management
planning.
1166 R. Kamal et al.Digital breast tomosynthesis as compared to
mammography, upgraded the BI-RADS category of one case
from BIRADS 1 to 2; another case from BIRADS 2 to 4;
and 16 cases from BIRADS 4 to 5.On the other hand, one case was downgraded from
BIRADS 3 to 1; eleven cases were downgraded from BIRADS
3 to 2; four cases from BIRADS 4 to 1; 13 cases from BIRADS
4 to 2 and five cases from BIRADS 4 to 3 (Fig. 2).
Fig. 4 (continued)
Breast tomosynthesis and MR mammography in evaluation of breast lesions 1167Also, the correlation between mammography BIRADS
scores and those of MRI revealed a highly significant p-value
of 0.001 (Table 5).
MRI as compared to mammography upgraded one case
from BIRADS 1 to 2; two cases from BIRADS 2 to 5; four
cases from BIRADS 3 to 4 (Fig. 2) and 12 cases from BIRADS
4 to 5.
MRI diagnosis downgraded the BI-RADS category of one
case from BIRADS 3 to 1; 12 cases from BIRADS 3 to 2
(Fig. 6); four cases from BIRADS 4 to 1; 22 cases from
BIRADS 4 to 2 (Fig. 3) and 9 cases from BIRADS 4 to 3.
The correlation between tomosynthesis BIRADS scores
and those of MRI revealed a highly significant p-value of
0.001 (Table 6).
Upon using both DBT and MRM evaluation in compar-
ison with mammography, upgraded one case from BIRADS
1 to 4 (Fig. 5); three cases from BIRADS 2 to 3; one case from
BIRADS 2 to 4; one case from BIRADS 2 to 5; and three cases
from BIRADS 3 to 4 and two cases were upgraded from
BIRADS 4 to 5.
On the other hand, one case was downgraded from
BIRADS 2 to 1; 4 cases were downgraded from BIRADS 3
to 2, 7 cases from BIRADS 4 to 2, 4 cases from BIRADS 4
to 3, and 2 cases from BIRADS 5 to 2; 1 case was downgraded
from BIRADS 5 to 3 and 2 cases were downgraded from
BIRADS 5 to 4.
Table 7 lists the correlation between the results of DBT,
MRM and the combined application of both modalities with
the results of the final outcome.
Correlation between the individual results of
tomosynthesis and MRM to the final outcome, revealed a
high significant correlation of p-value of 0.001. The added
results of both modalities when compared to the final
diagnosis revealed a significant correlation of
p-value = 0.035 (Table 8).4. Discussion
Previous studies focusing upon observer performance of DBT
compared to DM have shown contradictory results, varying
from a statistically significant advantage for DBT (13,14) to
no clear advantage for DBT (1,15). Other studies suggested
improved sensitivity of DBT over DM (7,8).
For example, in 2012 Savhn and his co-workers published a
study that aimed at comparing the ability of radiologists to
detect breast cancers using one-view DBT and two-view DM
in an enriched population of abnormal (diseased) patients
and benign and/or normal (healthy) patients. They concluded
that the diagnostic accuracy of DBT was superior to DM. The
sensitivity of DBT was significantly higher than that for DM
(average, 90% vs. average, 79%). The difference in specificity
was not significantly different (95%) but varied substantially
between readers (9).
The findings of Savhn and his co-workers, named a signif-
icantly higher sensitivity using DBT but a non-significant dif-
ference in specificity, which was inconsistent with the study
by Gur et al., who compared the performance of a combined
modality consisting of two-view DBT and two-view DM with
two-view DM, and found significantly higher specificity for the
combined modalities, but the difference in sensitivity was not
significant. The authors noted a non-significant improvement
in sensitivity when reading DBT alone (93%) as compared to
digital mammography alone (88%). The combination of DM
and DBT did not improve sensitivity compared to DBT
alone. Specificity was greatest with DBT combined with
DM, compared to DBT alone or to DM alone (72% vs 64%
vs 60%) (10).
Tagliafico et al. evaluated 52 consecutive recalledwomen and
the diagnostic accuracy was evaluated by two radiologists of
varying experience (Reader1 and Reader2). Overall sensitivity
was equal for both techniques (100% [95% CI, 91–100%] for
Fig. 5 Forty-five year old female presented with right breast upper outer stitching pain. (a) Right breast CC (right image) and CC (left
image) views of digital mammography showed no distinct abnormality; BI-RADS 1. (b) DBT CC view of the right breast showed upper
central cluster of microcalcifications (circle) that were overlapped by glandular tissue in the conventional mammogram. DBT guided cone
view (c) conventional DM and (d) DBT examinations and proper depiction of the right breast cluster of microcalcifications (arrow); BI-
RADS4. (e) Breast MR imaging; axial T2 FSE (right image), axial T2 STIR (middle image) and axial post contrast color mapping (left
image): a solitary focus is depicted corresponding to the microcalcific cluster only depicted by its contrast uptake (arrow). BI-RADS 4c
was assigned by MRM after considering wash out time/signal intensity curve pattern seen in (f). Pathological specimen revealed ductal
carcinoma in situ (DCIS) with micro invasion. DBT was the guide modality for lesion detection and proper diagnosis.
1168 R. Kamal et al.DBTand 100% [95%CI, 91–100%] forDM).Overall specificity
was higher for DBT (100% [95% CI, 91–100%]) than that for
DM (94% [95% CI, 91–100%]). The mean difference between
the two techniques was not significantly different presenting p
value of 0.43 (11).
Helvie et al. determined that more masses were detected by
DBT than conventional mammography. DBT detected 100%of cancers while only 71% were detected by conventional
mammography (16).
The findings of our study lie in concordance with those of
Helvie et al. where a significant difference in performance
between both DBT and DM was deduced. As regards DBT
results, out of the 103 lesions included in the study group, 23
were found to be true positive (22.3%), 63 were true negative
Fig. 5 (continued)
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negative (1.9%). This lies in contrast to the mammography
results where 22 were true positive (22%), 41 were true
negative (39.8%), 37 were false positive (35.9%), and 3 were
false negative (2.9%).
Therefore, in our study, both the sensitivity and speci-
ficity of DBT were better than those for DM. The sensitiv-
ity of DBT was 92% as compared to that of DM which
was 88%. Concerning specificity, DBT showed noticeably
high value (80.77%), in contrast to DM that was only
52.56%.
Also concerning the positive and negative predictive values
of DBT and DM, those for DBT (60.53% and 96.92%) were
higher than those for DM (37.29% and 93.18%).
Moreover, DBT showed better overall efficacy reaching
83.5% as compared to 61.17% for DM.
We have to admit that the specificity and accuracy
presented by DM were very low to be accepted on standard
basis; yet, such condition is a special situation of our work
as most of the malignant cases were of dense breast categories
(ACR 3 and 4).
In our study population, 10 cases were scored as ACR I
(10.2%), 27 cases as ACR II (27.5%), 56 cases as ACR III
(57.1%) and 6 cases as ACR IV (6.1%).
As mentioned before, not all DBT studies have yielded
positive results. Teertstra and co-workers, in the Netherlands
compared 513 diagnostic digital mammograms with tomosyn-
thesis. The study sample included patients with abnormalscreen examinations (26%), women with palpable findings
(44%), and those seeking a second opinion (30%). Using a
positive threshold of BIRADS Categories 0, 3, 4, and 5, the
authors reported similar sensitivity of 92.9% for both DBT
and DM and specificity of 86.1% with DM and of 84.4% with
DBT. There were 8 cancers that were false negative to DBT.
These results suggested no improvement for diagnostic DBT.
However, if the more commonly used positive threshold for
cancer was Categories 0, 4, or 5, then the sensitivity of DBT
was greater than DM (80% vs. 73%) with specificity of 96%
and 97% (1).
Kolb et al. in 2002 reported sensitivity for mammography
of 77.6% and specificity of 98.9%. They also stated that mam-
mographic sensitivity declined significantly with increasing
breast density (48% for the densest breast) and in younger
women with dense breasts (17). Both Brekelmans and Gilliland
and their co-workers have also stated similar results (18,19).
Previous studies evaluated different aspects for DBT in
contrast to DM such as image quality, recall rate and reading
time.
For example, Bernardi et al. in 2012 published the results of
a study that demonstrated the capability of DBT to improve
breast screening specificity and to reduce recall rates. They
found out that the proportion of true negative 3D triage was
slightly higher in dense than non-dense breasts, and also was
significantly associated with the type of lesion seen on imaging
(being highest for distortions, asymmetric densities, and
lesions with ill-defined margins) (20).
Fig. 6 Female patient 50 year old presented with palpable lump at the upper outer quadrant of the right breast. (a) Right breast digital
mammography CC view that showed upper outer dense mass with partly indistinct margins (arrow); BI-RADS 3. (b) DBT CC view of the
right breast showed upper outer evident circumscribed mass with dense and lucent (fat near density) components (arrows); BI-RADS 2. (c)
Axial MR breast images upper row: T1WI (right image), T2 FSE WI (left image) and lower row: T2 STIR WI (right image) and
subtraction post contrast (left image) showing right breast upper outer circumscribed small cystic mass (circle) with bloody (bright T1 and
low T2 signal intensity) and fatty (bright T1 and T2 and suppressed T2 STIR signal intensity) components suggestive of complicated cyst
likely fat necrosis that showed ring enhancement in the post contrast subtraction image; BI-RADS 2. Both DBT and MRM showed
specific diagnostic features of benign pathology.
1170 R. Kamal et al.Michell and co-workers in 2012 declared that the diagnostic
outcome for DBT was significantly greater for soft-tissue
lesions compared to microcalcifications (21).Similarly, in our current study, the use of 3 D tomosynthe-
sis allowed more confident up or down grading of the
BIRADS score of a lesion.
Table 7 Final outcome versus the individual DBT and MRI results cross tabulation.
Final outcome DBT MRM Total
Benign Malignant Benign Malignant DBT MRM
Benign 63 15 70 8 78 78
Malignant 2 23 2 23 25 25
Total 65 38 72 31 103 103
P value: 0.00.
Table 8 Correlation of the combined results of both DBT and
MRI with the final diagnosis.
DBT diagnosis MRM Total
Right Wrong
Right 80 6 86
Wrong 13 4 17
Total 93 10 103
P value: 0.035.
Breast tomosynthesis and MR mammography in evaluation of breast lesions 1171DBT had downgraded the BI-RADS category and
provided more accurate diagnosis to 22 lesions that could have
avoided tissue sampling. Such capability was elicited by the
better depiction of lesion margins allowed with DBT.
An important issue for the detection of breast malignancy is
the detection of microcalcifications. Microcalcifications are a
dominant indicator for DCIS. Early impressions on microcal-
cifications on DBT in relation to DM are equally visible, but
the morphological details of the individual calcification are
not well visualized on DBT (7).
The visualization of microcalcifications was better with DM
than with DBT probably because of the cross-sectional nature
of DBT; existing microcalcifications are visualized in different
tomosynthesis planes (22). Another more recent study stated
that DBT has equal or greater clarity regarding microcalcifica-
tions compared with DM using certain reconstruction
algorithms (23).
In our current study, four DCIS lesions were detected as
microcalcific clusters on both 2D mammography and 3D
DBT and they were clearly seen in both modalities.
The other aim of our study is the evaluation of the addi-
tional role of MRM as an adjunct to DM in the evaluation
of breast diseases.
In our study, as regards the results of MRI, out of the
included 103 breast lesions only two lesions (1.9%) were false
negative and eight lesions were false positive (7.8%), reflecting
a high sensitivity and specificity of 92% and 90% respectively.
Again, within our study, the performance of MRI was
better than that of mammography which showed a sensitivity
of 88% and a specificity of 52%. Also the positive and the neg-
ative predictive values as well as the efficacy of breast MRI
were higher than those of mammography.
Many other studies have been conducted to assess the
sensitivity and specificity of breast MRI in detecting breast
cancer, in the both diagnostic and screening settings.
For example, our results were very similar to those of
Sardanelli and Podo who conducted a study to prospectivelycompare clinical breast examination, mammography, ultra-
sound and MRI for screening women at genetic-familial high
risk for breast cancer and compared results with pathological
findings as standard. The concluded sensitivity was as follows:
CBE, 50%; mammography, 59%; ultrasound, 65%; and MRI,
94% (24).
Another study was conducted by Warren and his
co-workers in 2005. They prospectively determined sensitivity
and specificity of breast MRI in a screening and symptomatic
population. By taking the reading with the highest score (most
likely to be malignant) from each double-read study, sensitivity
was 91% and specificity was 81%. Specificity, but not sensitiv-
ity, was higher in women younger than 50 years (P= .02) (25).
In Netherlands, Stoutjesdijk et al., Tilanus-Linthorst et al.
and Kriege et al. conducted similar studies, comparing breast
MRI to mammography and physical examination in detecting
cancer in women with elevated risk. Stoutjesdijk et al. studied
179 women, Tilanus-Linthorst et al. studied 109 women and
Kriege et al. studied 1909 women. The concluded sensitivities
for MRI cancer detection were 100% for both Stoutjesdijk
et al. and Tilanus-Linthorst et al. and it was remarkably lower
for Kriege et al., reaching 79.5%. However, specificities were
more or less similar, reaching 89.3% and 89.9%, respectively.
On the other hand, concerning mammography, the sensitivity
and specificity for Stoutjesdijk et al. were 42% and 96%
respectively (26–28).
The results of both Kuhl in Germany and Podo et al. in
Italy were similar to those of Stoutjesdijk et al. and Tilanus-
Linthorst et al. where they both concluded a sensitivity of
100% for breast cancer detection with MRI and a specificity
of 95% and 99%, respectively (29,30).
By reviewing the results of our study as well as the previ-
ously mentioned others, it can be deduced that breast MRI
can be very valuable for lesion detection and characterization
(Fig. 3 and 6), owing to its excellent sensitivity and moderate
specificity and can thus be applied in both the screening and
diagnostic settings, as indicated in order to improve diagnosis
of disease and thus ameliorate management options.
We have to mention that there are still limitations to breast
MRI: it is expensive and not as widely available as mammog-
raphy. Deficiencies with specificity remain a challenge to the
breast imaging community, and controversies regarding the
best indication for clinical use. Finally the risks of IV
Gd-DTPA in patients with renal impairment also remain a
drawback.
Also sometimes pathology may be overlooked in MR
images as in case of clusters of microcalcifications which is
one of the early signs of breast cancer and at this time
mammogram is mandatory for pathology depiction (Fig. 5).
1172 R. Kamal et al.As stated before, both DBT and breast MRI showed better
performance as regards sensitivity and specificity than did
mammography. Both imaging modalities can add a lot to the
information gained from classic mammography not just
regarding diagnosis but also in view of precise disease
distribution (Fig. 4).
We still have the debate of which modality to proceed
following digital mammogram in order to seek precise
diagnosis and prompt management.
5. Conclusion
Both DBT and MRM should go hand in hand with DM.
Adding either of these modalities to the classic examination
enhances diagnosis and precise disease distribution.
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